Effects of thymosin alpha-1 on erythrocyte lipid levels and erythrocyte membrane (Na(+)-K+)-ATPase activity in experimental hypercholesterolemia.
Gökkuşu. C C; Ademoğlu. E E; Oz. H H; Türkoğlu. U M UM
Key Findings
- Thymosinâalphaâ1 reduced erythrocyte lipid levels in hypercholesterolemic rabbits
- Naâș/KâșâATPase activity in redâcell membranes increased after thymosinâalphaâ1 treatment
- The study was performed in an animal model of high cholesterol, not humans
Practical Outcomes
- The results are interesting but not actionable for most biohackers yet. More human research is needed before recommending thymosinâalphaâ1 for cholesterol or membrane health, and dosing protocols remain undefined.
Summary
In a rabbit study, giving thymosinâalphaâ1 lowered the amount of fat in red blood cells and boosted the activity of a key membrane pump (Naâș/KâșâATPase). These changes were seen in animals with high cholesterol, suggesting the peptide might influence blood lipid handling and cell membrane function, but the work is preâclinical and not directly ready for human use.
Abstract
Thymosin alpha-1 is an active polypeptide isolated from thymus. This polypeptide is widely used in the diagnosis and treatment of many diseases, especially immune diseases. In this present study, we examined the effects of thymosin alpha-1 on plasma and erythrocyte lipid levels and the changes in erythrocyte membrane (Na+, K+)ATPase activity in hypercholesterolemic rabbits. The erythrocyte lipid levels decreased, whereas the erythrocyte membrane (Na+, K+)ATPase activity increased significantly in these rabbits after thymosin alpha-1 injection. These findings suggest that thymosin alpha-1 is effective on both the lipid level and erythrocyte membrane (Na+, K+)ATPase activity.
Study Information
pubmed
1997